Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.

O'Brien B, Knight-West O, Walker N, Parag V, Bullen C.

Tob Induc Dis. 2015 Mar 24;13(1):5. doi: 10.1186/s12971-015-0030-2. eCollection 2015.

2.

Cytisine versus nicotine for smoking cessation.

Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C.

N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764.

3.

Abrupt nicotine reduction as an endgame policy: a randomised trial.

Walker N, Fraser T, Howe C, Laugesen M, Truman P, Parag V, Glover M, Bullen C.

Tob Control. 2014 Nov 14. pii: tobaccocontrol-2014-051801. doi: 10.1136/tobaccocontrol-2014-051801. [Epub ahead of print]

PMID:
25398562
4.

Effect of a family-centered, secondhand smoke intervention to reduce respiratory illness in indigenous infants in Australia and New Zealand: a randomized controlled trial.

Walker N, Johnston V, Glover M, Bullen C, Trenholme A, Chang A, Morris P, Segan C, Brown N, Fenton D, Hawthorne E, Borland R, Parag V, Von Blaramberg T, Westphal D, Thomas D.

Nicotine Tob Res. 2015 Jan;17(1):48-57. doi: 10.1093/ntr/ntu128. Epub 2014 Aug 25.

5.

Pharmacy-based screening for atrial fibrillation in high-risk Maori and Pacific populations.

Walker N, Doughty R, Parag V, Harrison J, Bennett M, Freedman B.

N Z Med J. 2014 Jul 18;127(1398):128-31. No abstract available.

PMID:
25146870
6.

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Parag V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A.

BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.

7.

Electronic cigarettes and smoking cessation: a quandary? - Authors' reply.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N.

Lancet. 2014 Feb 1;383(9915):408-9. doi: 10.1016/S0140-6736(14)60146-X. No abstract available.

PMID:
24485579
8.

Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012.

Krishnamurthi R, Jones A, Barber PA, Barker-Collo S, McPherson K, Bennett D, Rush E, Suh F, Starkey N, Theadom A, Parag V, Rathnasabapathy Y, Feigin VL; ARCOS IV Programme Group.

Int J Stroke. 2014 Jan;9(1):140-7. doi: 10.1111/ijs.12108. Epub 2013 Oct 27.

PMID:
24165287
9.

Reducing recurrent stroke: methodology of the motivational interviewing in stroke (MIST) randomized clinical trial.

Krishnamurthi R, Witt E, Barker-Collo S, McPherson K, Davis-Martin K, Bennett D, Rush E, Suh F, Starkey N, Parag V, Rathnasabapathy Y, Jones A, Brown P, Te Ao B, Feigin VL; ARCOS IV Programme Group.

Int J Stroke. 2014 Jan;9(1):133-9. doi: 10.1111/ijs.12107. Epub 2013 Oct 27.

PMID:
24165269
10.

Electronic cigarettes for smoking cessation: a randomised controlled trial.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N.

Lancet. 2013 Nov 16;382(9905):1629-37. doi: 10.1016/S0140-6736(13)61842-5. Epub 2013 Sep 9.

PMID:
24029165
11.

Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation.

Bullen C, Williman J, Howe C, Laugesen M, McRobbie H, Parag V, Walker N.

BMC Public Health. 2013 Mar 8;13:210. doi: 10.1186/1471-2458-13-210.

12.

Pentoxifylline for treating venous leg ulcers.

Jull AB, Arroll B, Parag V, Waters J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001733. doi: 10.1002/14651858.CD001733.pub3. Review.

PMID:
23235582
13.

Incidence of traumatic brain injury in New Zealand: a population-based study.

Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, Dowell A, Brown P, Parag V, Kydd R, Jones K, Jones A, Ameratunga S; BIONIC Study Group.

Lancet Neurol. 2013 Jan;12(1):53-64. doi: 10.1016/S1474-4422(12)70262-4. Epub 2012 Nov 22.

PMID:
23177532
14.

Prevalence and predictors of 6-month fatigue in patients with ischemic stroke: a population-based stroke incidence study in Auckland, New Zealand, 2002-2003.

Feigin VL, Barker-Collo S, Parag V, Hackett ML, Kerse N, Barber PA, Theadom A, Krishnamurthi R; Auckland Regional Community Stroke Study Group.

Stroke. 2012 Oct;43(10):2604-9. Epub 2012 Jul 31.

15.

The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.

Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, Laugesen M, Parag V, Whittaker R.

Addiction. 2012 Oct;107(10):1857-67. doi: 10.1111/j.1360-0443.2012.03906.x. Epub 2012 May 17.

PMID:
22594651
16.

MEMO--a mobile phone depression prevention intervention for adolescents: development process and postprogram findings on acceptability from a randomized controlled trial.

Whittaker R, Merry S, Stasiak K, McDowell H, Doherty I, Shepherd M, Dorey E, Parag V, Ameratunga S, Rodgers A.

J Med Internet Res. 2012 Jan 24;14(1):e13. doi: 10.2196/jmir.1857.

17.

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Walker N, Howe C, Bullen C, McRobbie H, Glover M, Parag V, Williman J, Veale R, Nosa V, Barnes J.

BMC Public Health. 2011 Nov 21;11:880. doi: 10.1186/1471-2458-11-880.

18.

Neuropsychological profiles of 5-year ischemic stroke survivors by Oxfordshire stroke classification and hemisphere of lesion.

Barker-Collo S, Starkey N, Lawes CM, Feigin V, Senior H, Parag V.

Stroke. 2012 Jan;43(1):50-5. doi: 10.1161/STROKEAHA.111.627182. Epub 2011 Oct 13.

19.

Problem-solving therapy for people who present to hospital with self-harm: Zelen randomised controlled trial.

Hatcher S, Sharon C, Parag V, Collins N.

Br J Psychiatry. 2011 Oct;199(4):310-6. doi: 10.1192/bjp.bp.110.090126. Epub 2011 Aug 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk